Are all patients with COPD likely to benefit from LAMA+LABA+ICS triple therapy? The GOLD guidance has been updated. What’s new, what’s changed, and how should the revised recommendations be put into practice? Are people with COPD more susceptible to COVID infection? Or is inhaled corticosteroid therapy protective? What does the evidence say?
Join us, as Dr. Nirupama Putcha from the Division of Pulmonology and Critical Care at Johns Hopkins University School of Medicine, explores these and other critical topics — in this issue of ePulmonology Review.
Assistant Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Johns Hopkins School of Medicine
Professor of Medicine, Epidemiology and Environmental Health Sciences
Johns Hopkins University School of Medicine
Senior Clinic Nurse Coordinator
Johns Hopkins Medicine
1.0 hour Physicians
1.0 contact hour Nurses
Launch date: March 30, 2022
Expiration date: March 29, 2024